{"id":"W2080011730","doi":"10.1097/ppo.0b013e3182758985","title":"Monoclonal Antibodies and Other Targeted Therapies for Pancreatic Cancer","year":2012,"lang":"en","type":"review","venue":"The Cancer Journal","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pancreas Centre (Canada)","funders":"","keywords":"Pancreatic cancer; Gemcitabine; Erlotinib; Medicine; Oncology; FOLFIRINOX; Cancer; Targeted therapy; Adenocarcinoma; Internal medicine; CA19-9; Cancer research; Epidermal growth factor receptor; Irinotecan","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001012325,0.0003544903,0.001957074,0.0001323295,0.0003857157,0.00005453068,0.0002403213,0.0002318994,0.001307846],"category_scores_gemma":[0.00006741979,0.0001700991,0.0003661246,0.0001253551,0.0003437181,0.00005608822,0.00005513111,0.0008048764,0.00001139776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002722213,"about_ca_system_score_gemma":0.00109685,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001341134,"about_ca_topic_score_gemma":0.00003162937,"domain_scores_codex":[0.9981913,0.0002291129,0.0005098052,0.0002180675,0.0002866275,0.0005651056],"domain_scores_gemma":[0.9985534,0.0004220781,0.0004021886,0.0002595183,0.0001610197,0.0002017867],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001580142,0.00004553598,0.01311676,0.006853114,0.003495301,0.000008593517,0.0006518165,1.400723e-7,0.000004828646,0.00008952638,0.006861087,0.9687153],"study_design_scores_gemma":[0.0007678103,0.0001286492,0.001259292,0.00621612,0.008069349,0.000682947,0.0001016285,0.00002073011,0.000001286242,0.0002335429,0.9823262,0.000192447],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001116921,0.9958611,0.0000695065,0.0009463851,0.000350913,0.001174599,0.0001444441,0.00001554273,0.0003206381],"genre_scores_gemma":[0.00006596864,0.9921814,0.0005357046,0.0004706317,0.003271974,0.0006399573,0.000009209368,0.00007576695,0.002749412],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9754651,"threshold_uncertainty_score":0.9996051,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1746658641995349,"score_gpt":0.4643551876132151,"score_spread":0.2896893234136801,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}